Home
Screener
GERN
profile

GERN Company Profile and Key Details

NASDAQ : GERN

Geron Corporation

$2.91

0.06+2.11%

At Close 4:00 PM

$2.97

0.06+2.06%

Pre-Market 04:17 AM

56.45

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

GERN Stock Price Chart

Stock Price Today

Geron Corporation (GERN) stock surged +2.11%, trading at $2.91 on NASDAQ, up from the previous close of $2.85. The stock opened at $2.85, fluctuating between $2.82 and $2.94 in the recent session.

Stock Snapshot

2.85

Prev. Close

2.85

Open

1.76B

Market Cap

604.5M

Number of Shares

2.82

Day Low

2.94

Day High

-9.09

P/E Ratio

93.41%

Free Float in %

-0.32

EPS (TTM)

0.42

Book Value

-0.28

Cash Flow per Share

11.28M

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 04, 2025	2.85	2.94	2.82	2.91	11.35M
Feb 03, 2025	2.81	2.92	2.78	2.85	19.33M
Jan 31, 2025	2.89	2.95	2.85	2.87	10.69M
Jan 30, 2025	2.89	2.92	2.79	2.88	10.06M
Jan 29, 2025	2.99	3.04	2.86	2.89	10.57M
Jan 28, 2025	2.95	3.04	2.92	3.00	7.4M
Jan 27, 2025	3.00	3.09	2.92	2.96	6.72M
Jan 24, 2025	3.02	3.12	2.98	3.01	6.68M
Jan 23, 2025	2.95	3.03	2.90	3.02	5.04M
Jan 22, 2025	2.98	3.07	2.95	2.99	5.68M
Jan 21, 2025	2.95	3.00	2.90	2.96	6.25M
Jan 17, 2025	2.92	2.99	2.85	2.89	8.64M
Jan 16, 2025	2.99	3.03	2.91	2.92	6.01M
Jan 15, 2025	3.01	3.09	2.96	3.01	6.6M
Jan 14, 2025	3.02	3.09	2.87	2.94	12.41M
Jan 13, 2025	3.10	3.10	2.80	2.98	23.39M
Jan 10, 2025	3.38	3.45	3.15	3.17	17.98M
Jan 08, 2025	3.39	3.46	3.36	3.42	8.04M
Jan 07, 2025	3.45	3.50	3.37	3.40	7.22M
Jan 06, 2025	3.55	3.59	3.37	3.43	16.89M

Contact Details

Foster City, CA 94404

United States

Website: https://www.geron.comContact: 650 473 7700

About Company

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.

Frequently Asked Questions

What is the current Geron Corporation (GERN) stock price?

Geron Corporation (NASDAQ: GERN) stock price is $2.91 in the last trading session. During the trading session, GERN stock reached the peak price of $2.94 while $2.82 was the lowest point it dropped to. The percentage change in GERN stock occurred in the recent session was 2.11% while the dollar amount for the price change in GERN stock was $0.06.

GERN's industry and sector of operation?

The NASDAQ listed GERN is part of Biotechnology industry that operates in the broader Healthcare sector. Geron Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of GERN?

Ms. Melissa A. Kelly Behrs
Executive Vice President of Bus. Operations & Chief Alliance Officer
Dr. Andrew J. Grethlein
Executive Vice President & Chief Operating Officer
Mr. Anil Kapur
Executive Vice President of Corporation Strategy & Chief Commercial Officer
Mr. Scott Samuels
Executive Vice President, Chief Legal Officer & Corporation Sec.
Mr. Stephen N. Rosenfield J.D.
Executive Vice President, Chief Legal Officer & Corporation Sec.
Dr. John A. Scarlett M.D.
Chairman, Pres & Chief Executive Officer
Ms. Shannon Odam
Vice President of HR
Mr. Edward E. Koval
Executive Vice President & Chief Bus. Officer
Dr. Faye Feller M.D.
Executive Vice President & Chief Medical Officer
Ms. Olivia Kyusuk Bloom
Executive Vice President of Fin., Chief Financial Officer & Treasurer

How GERN did perform over past 52-week?

GERN's closing price is 77.44% higher than its 52-week low of $1.64 where as its distance from 52-week high of $5.34 is -45.51%.

How many employees does GERN have?

Number of GERN employees currently stands at 141.

Link for GERN official website?

Official Website of GERN is: https://www.geron.com

How do I contact GERN?

GERN could be contacted at phone 650 473 7700 and can also be accessed through its website. GERN operates from 919 East Hillsdale Boulevard, Foster City, CA 94404, United States.

How many shares of GERN are traded daily?

GERN stock volume for the day was 11.28M shares. The average number of GERN shares traded daily for last 3 months was 10.9M.

What is the market cap of GERN currently?

The market value of GERN currently stands at $1.76B with its latest stock price at $2.91 and 604.5M of its shares outstanding.

Employees	141
Beta	0.52
Sales or Revenue	$237.00K
5Y Sales Change%	-0.931%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology